Global Stents Market Expected To Be Worth US$ 16.5 Billion By 2022
Bibliographic record
Abstract
Market Research Engine has published a new report titled as “Stents Market By Material Analysis (Metallic Biomaterials, Polymers Biomaterials, Natural Biomaterials); By Type Analysis (Coronary Stents, Peripheral Stents, Stent-Related Implants) and By Regional Analysis – Global Forecast by 2016 - 2022”\n\nA stent is a small and tiny wire web like tube that a special medical practitioner implants in the body of the patient in order to restore blood flow and support the vessel wall. Stents help to keep the coronary arteries open in order to decrease the rate of a heart attack. A stent reinstates the blood flow and flow of other fluids, based on where the stent is placed. One of the significant causes behind growing cardiovascular conditions is getting habitual to unhealthy lifestyle. Evolving way of life, for example, smoking, physical inactivity, and irregular eating habits hamper the health of the heart. These conditions are prompting probability of hypertension, stoutness, and blockages in supply routes. Thus, aging of population is another element that is driving the development of these items at a critical rate. The use of latest trends in medical field, for example, scaffolds, Bioresorbable stents, bifurcation stent, and biodegradable polymer with an appropriation of more up to date systems and negligibly intrusive strategies are inclining in this industry. These items are optional for bypass surgery. What's more, when utilized as a part of insignificantly obtrusive methods, they offer certain points of interest over traditional surgeries, for example, less recovery time, shorter scars, less physical injury and less danger of infection and less bleeding.\n\nThe Global Stents Market is expected to exceed more than US$ 16.6 Billion by 2022 at a CAGR of 9.5% in the given forecast period.\n\nYou Can Browse Full Report: https://www.marketresearchengine.com/stents-market-report\n\nThe major driving factors of Global Stents Market are as follows:\n\n\n\tGrowing ageing population and rising prevalence of chronic diseases\n\tNew developing technological advancements in the field of stents\n\tDevelopment of healthcare infrastructure in developing countries\n\tEnhanced insurance and repayment\n\n\nThe restraining factors of Global Stents Market are as follows:\n\n\n\tHigh cost of treatment related with stent implants\n\tStrict approval process for stents\n\tAvailability of optional treatment method\n\n\nThe Global Stents Market is segmented on the lines of its material, type and regional. Based on material segmentation it covers metallic biomaterials, polymers biomaterials, natural biomaterials. Based on type segmentation it covers coronary stents, peripheral stents, stent-related implants, The Global Stents Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.\n\nThis report provides:\n \n1) An overview of the global market for Global Stents Market and related technologies.\n2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.\n3) Identifications of new market opportunities and targeted promotional plans for Global Stents Market.\n4) Discussion of research and development, and the demand for new products and new applications.\n5) Comprehensive company profiles of major players in the industry.\n\nREPORT SCOPE: \n\nThe scope of the report includes a detailed study of global and regional markets on Global Stents Market with the reasons given for variations in the growth of the industry in certain regions.\n \nThe report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corp., C. R. Bard, Inc, Elixir Medical Corp., Medtronic plc, Microport Scientific Corp., Stentys S.A., Terumo Corporation. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.\n\nThe Global Stents Market has been segmented as below:\n\nBy Material Analysis:\n\n\n\tMetallic Biomaterials\n\tPolymers Biomaterials\n\tNatural Biomaterials\n\n\nBy Type Analysis:\n\n\n\tCoronary Stents\n\n\n\n\tDrug-Eluting Stents (DES)\n\tBare-Metal Coronary Stents\n\tBioabsorbable Stents\n\n\n\n\tPeripheral Stents\n\n\n\n\tIliac\n\tFemoral-Popliteal\n\tRenal\n\tCarotid\n\n\n\n\tStent-Related Implants\n\n\n\n\tSynthetic Grafts\n\tVena Cava Filters\n\n\nBy Regional Analysis:\n\n\n\tNorth America\n\tEurope\n\tAsia-Pacific\n\tRest of the World\n\n\nRequest Sample Report: https://www.marketresearchengine.com/stents-market-report\n\n \n\nTable of Contents\n\n1 INTRODUCTION\n\n2 EXECUTIVE SUMMARY\n\n3 MARKET OVERVIEW\n\n4 WORLD STENTS MARKET, BY PRODUCT\n\n5 WORLD STENTS MARKET, BY BIOMATERIAL\n\n6 WORLD STENTS MARKET, BY GEOGRAPHY\n\n7 COMPANY PROFILES\n\n7.1 Abbott Laboratories\n\n7.2 B. Braun Melsungen AG\n\n7.3 Biotronik SE & Co. KG\n\n7.4 Boston Scientific Corporation\n\n7.5 C. R. Bard, Inc.\n\n7.6 Elixir Medical Corporation\n\n7.7 Medtronic plc\n\n7.8 Microport Scientific Corporation\n\n7.9 Stentys S.A.\n\n7.10 Terumo Corporation\n\n \n\nMedia Contact\n\nCompany Name: Market Research Engine\n\nContact Person: John Bay\n\nEmail: john@marketresearchengine.com\n\nPhone: +1-855-984-1862\n\nCountry: United States\n\nWebsite: https://www.marketresearchengine.com/
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.002 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.002 | 0.002 |
| Science and technology studies | 0.001 | 0.000 |
| Scholarly communication | 0.005 | 0.003 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.002 | 0.002 |
| Insufficient payload (model declined to judge) | 0.183 | 0.196 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".